BDBM359710 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 92

SMILES Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(CO)C4)c3)ccc12

InChI Key InChIKey=KXOHCDTXIZSUSX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 359710   

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM359710(N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(hydr...)
Affinity DataIC50: 355nMAssay Description:Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetKallikrein-1(Human)
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM359710(N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(hydr...)
Affinity DataIC50: 7.51E+3nMAssay Description:KLK1 inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent